Hofseth Biocare Asa Stock Net Income
| HOFBF Stock | USD 0.17 0.00 0.00% |
Hofseth BioCare technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Hofseth BioCare's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Hofseth BioCare's valuation are provided below:Hofseth BioCare ASA does not presently have any fundamental trends for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Hofseth |
Hofseth BioCare 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hofseth BioCare's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hofseth BioCare.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in Hofseth BioCare on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Hofseth BioCare ASA or generate 0.0% return on investment in Hofseth BioCare over 90 days. Hofseth BioCare is related to or competes with Paradigm Biopharmaceutica, Kintor Pharmaceutical, Innate Pharma, Scancell Holdings, HLS Therapeutics, VITA 34, and Nuo Therapeutics. Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway a... More
Hofseth BioCare Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hofseth BioCare's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hofseth BioCare ASA upside and downside potential and time the market with a certain degree of confidence.
Hofseth BioCare Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hofseth BioCare's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hofseth BioCare's standard deviation. In reality, there are many statistical measures that can use Hofseth BioCare historical prices to predict the future Hofseth BioCare's volatility.Hofseth BioCare ASA Backtested Returns
We have found three technical indicators for Hofseth BioCare ASA, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and Hofseth BioCare are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Hofseth BioCare ASA has perfect predictability. Overlapping area represents the amount of predictability between Hofseth BioCare time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hofseth BioCare ASA price movement. The serial correlation of 1.0 indicates that 100.0% of current Hofseth BioCare price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Hofseth BioCare ASA reported net income of (126.46 Million). This is 137.06% lower than that of the Healthcare sector and 280.54% lower than that of the Biotechnology industry. The net income for all United States stocks is 122.15% higher than that of the company.
Hofseth Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hofseth BioCare's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Hofseth BioCare could also be used in its relative valuation, which is a method of valuing Hofseth BioCare by comparing valuation metrics of similar companies.Hofseth BioCare is currently under evaluation in net income category among its peers.
Hofseth Fundamentals
| Return On Equity | -0.95 | |||
| Return On Asset | -0.19 | |||
| Profit Margin | (1.14) % | |||
| Operating Margin | (1.07) % | |||
| Current Valuation | 103.14 M | |||
| Shares Outstanding | 395.08 M | |||
| Shares Owned By Insiders | 52.50 % | |||
| Shares Owned By Institutions | 20.43 % | |||
| Price To Book | 16.71 X | |||
| Price To Sales | 1.21 X | |||
| Revenue | 87.62 M | |||
| Gross Profit | 28.51 M | |||
| EBITDA | (87.72 M) | |||
| Net Income | (126.46 M) | |||
| Cash And Equivalents | 30.57 M | |||
| Cash Per Share | 0.09 X | |||
| Total Debt | 23.79 M | |||
| Debt To Equity | 1.25 % | |||
| Current Ratio | 0.92 X | |||
| Book Value Per Share | 0.39 X | |||
| Cash Flow From Operations | (61.78 M) | |||
| Earnings Per Share | (0.04) X | |||
| Number Of Employees | 17 | |||
| Beta | 0.54 | |||
| Market Capitalization | 130.38 M | |||
| Total Asset | 415.97 M | |||
| Z Score | 3.0 | |||
| Net Asset | 415.97 M |
About Hofseth BioCare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hofseth BioCare ASA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hofseth BioCare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hofseth BioCare ASA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Hofseth Pink Sheet
Hofseth BioCare financial ratios help investors to determine whether Hofseth Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hofseth with respect to the benefits of owning Hofseth BioCare security.